The following is a summary of “Association of Oncogene Driver Mutations with Recurrence and Survival in Stage I Nonsmall Cell ...

PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit looks back on the progress made toward better understanding and ...

The U.S. Food and Drug Administration has declined to approve an injectable version of Johnson & Johnson's drug Rybrevant for ...

Lung cancer is among the most common cancers worldwide and is the leading cause of ... However, doctors say sometimes they ...

Nichole Andrews told Newsweek about a "sustainable, enjoyable, and scientifically supported for cancer risk reduction" diet.

An FDA-approved drug used to treat multiple myeloma and lymphoma also shrank tumors in non-small cell lung cancer (NSCLC) ...

Pancreatic cancer has recently been included in the list of diseases about which Brazil's National Cancer Institute (INCA) ...

Planegg/Martinsried, December 9, 2024.Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an oncology platform company focused on the research and development of T cell receptor ...

The FDA has granted accelerated approval to zenocutuzumab for treating patients with advanced pancreatic cancer or non-small ...

A new method can improve treatment for patients with chronic myeloid leukemia by predicting which medication will be most ...

Aflatoxin from primary smoke and ETS is the likely carcinogen, as these cancers are more often associated with tobacco use. Most recently, p53 mutations have been found in ETS lung cancer patients.

some individuals remain unaware of the common signs of cancer. Symptoms can vary and are sometimes not immediately obvious. Stephen, a man who was diagnosed with lung cancer at 29, has shared his ...